Exact Mass: 428.2199
Exact Mass Matches: 428.2199
Found 500 metabolites which its exact mass value is equals to given mass value 428.2199
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Irbesartan
Irbesartan is an angiotensin receptor blocker (ARB) used mainly for the treatment of hypertension. It competes with angiotensin II for binding at the AT1 receptor subtype. Unlike ACE inhibitors, ARBs do not have the adverse effect of dry cough. The use of ARBs is pending revision due to findings from several clinical trials suggesting that this class of drugs may be associated with a small increased risk of cancer. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2774 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].
Austalide L
Austalide L is a mycotoxin produced by Aspergillus ustu
Taraxacolide 1-O-b-D-glucopyranoside
*Constituent of Taraxacum officinale (dandelion). Taraxacolide 1-O-b-D-glucopyranoside is found in many foods, some of which are coffee and coffee products, beverages, alcoholic beverages, and tea. Taraxacolide 1-O-b-D-glucopyranoside is found in alcoholic beverages. *Taraxacolide 1-O-b-D-glucopyranoside is a constituent of Taraxacum officinale (dandelion
Bedoradrine
Falipamil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Xanthine amine congener
Zaldaride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
Hypochoeroside A
Hypochoeroside a belongs to germacranolides and derivatives class of compounds. Those are sesquiterpene lactones with a structure based on the germacranolide skeleton, characterized by a gamma lactone fused to a 1,7-dimethylcyclodec-1-ene moiety. Hypochoeroside a is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Hypochoeroside a can be found in endive, which makes hypochoeroside a a potential biomarker for the consumption of this food product.
Sphaeranthanolide
Sonchuside F
Sonchuside G
11beta,13-dihydroparthenolide-14-O-beta-D-glucopyranoside
(E,E)-3beta-O-beta-D-glucopyranosyl-9beta-hydroxy-6beta,7alpha,11betaH-germacra-1(10),4-dien-12,6-olide|scorzoaustriacoside
4alpha,5alpha-epoxy-10alpha,11beta,13H,14H-1-epi-inuviscolide 3-beta-D-glucoside
(5-angeloyloxytiglinoyloxy)-costunolide|<5-angeloyloxytiglinoyloxy>-costunolide
3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-(alpha-xylopyranoside-2-O-acetate)|3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-
13,14-dihydroxy-15,16 dimethoxy-(-)-6alpha-hydroxy-5alpha,8alpha,9alpha,10alpha-cleroda-3-en-18-oic acid
(1R,2S,4S,5R,6R,9S)-2-hydroxy-11-oxoallocedra-13-oic acid 13-O-beta-D-glucopyranosyl ester
14-O-beta-D-glucopyranosyl-6-deoxy-3,4-dehydrofloridanolide|dunnianolide A
1-(2-Amino-1-oxopropyl)-2,3,3alpha, 13alpha, 14,15,16,18alpha-octahydro-8-methoxy-5,9-metheno-9H-dipyrrolo[3,2-b:1,2-e][1,5,8]oxadiazacyclopentadecine-13,18-(1H,12H)-dione
3,4-dimethoxy-benzoic acid 11-oxo-dodecahydro-7,14-methano-dipyrido[1,2-a;1,2-e][1,5]diazocin-2-yl ester|Cineverin|Cineverin (13-Veratroyloxy-lupanin)
1beta-[(E-p-methoxycinnamoyl)oxy]-6alpha-hydroxyisodrimeninol
4alpha-hydroxy-5alpha,8betaH-eudesman-7(11)-en-8alpha,12-olide-15-O-beta-D-glucopyranoside|sarcaglaboside H
5beta,11-dihydroxy-iphionan-4-one-11-O-(alpha-xylopyranoside-2-O-acetate)|5beta,11-dihydroxy-iphionan-4-one-11-O-
3beta-hydroxy-4aH-3-dihydrosantamarine-1beta-D-glucopyranoside
4,5-dioxo-seco-gamma-eudesmol-(alpha-xylopyranoside-2-O-acetate)|4,5-dioxo-seco-gamma-eudesmol-
CAY10594
CAY10594 is a potent phospholipase D2 (PLD2) inhibitor both in vitro (IC50=140 nM) and in cells (IC50=110 nM)[1]. CAY10594 strongly inhibits the invasive migration of breast cancer cells in vitro and ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis[2].
irbesartan
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1074 CONFIDENCE standard compound; INTERNAL_ID 2094 CONFIDENCE standard compound; INTERNAL_ID 8187 Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].
Irbesartan (Avapro)
Irbesartan. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=138402-11-6 (retrieved 2024-07-09) (CAS RN: 138402-11-6). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].
(2R,2R,4aS,6R,8aS)-6,7-diformyl-4-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[benzofuran-2,1-naphthalen]-6-yl acetate
((S)-2-((E)-6-((R)-3,3-dimethyloxiran-2-yl)-4-methylhex-3-en-1-yl)-8-formyl-5-hydroxy-2-methyl-2H-chromen-7-yl)methyl acetate
Ala Glu Ile Pro
Ala Glu Leu Pro
Ala Glu Pro Ile
Ala Glu Pro Leu
Ala His Thr Thr
Ala Ile Glu Pro
Ala Ile Pro Glu
Ala Lys Asn Pro
Ala Lys Pro Asn
Ala Leu Glu Pro
Ala Leu Pro Glu
Ala Asn Lys Pro
Ala Asn Pro Lys
Ala Asn Pro Gln
Ala Asn Gln Pro
Ala Pro Glu Ile
Ala Pro Glu Leu
Ala Pro Ile Glu
Ala Pro Lys Asn
Ala Pro Leu Glu
Ala Pro Asn Lys
Ala Pro Asn Gln
Ala Pro Gln Asn
Ala Gln Asn Pro
Ala Gln Pro Asn
Ala Thr His Thr
Ala Thr Thr His
Cys Ile Pro Pro
Cys Leu Pro Pro
Cys Pro Ile Pro
Cys Pro Leu Pro
Cys Pro Pro Ile
Cys Pro Pro Leu
Asp Pro Val Val
Asp Val Pro Val
Asp Val Val Pro
Glu Ala Ile Pro
Glu Ala Leu Pro
Glu Ala Pro Ile
Glu Ala Pro Leu
Glu Ile Ala Pro
Glu Ile Pro Ala
Glu Leu Ala Pro
Glu Leu Pro Ala
Glu Pro Ala Ile
Glu Pro Ala Leu
Glu Pro Ile Ala
Glu Pro Leu Ala
Gly Lys Pro Gln
Gly Lys Gln Pro
Gly Pro Lys Gln
Gly Pro Gln Lys
Gly Pro Gln Gln
Gly Gln Lys Pro
Gly Gln Pro Lys
Gly Gln Pro Gln
Gly Gln Gln Pro
His Ala Thr Thr
His Ser Ser Val
His Ser Val Ser
His Thr Ala Thr
His Thr Thr Ala
His Val Ser Ser
Ile Ala Glu Pro
Ile Ala Pro Glu
Ile Cys Pro Pro
Ile Glu Ala Pro
Ile Glu Pro Ala
Ile Pro Ala Glu
Ile Pro Cys Pro
Ile Pro Glu Ala
Ile Pro Pro Cys
Lys Ala Asn Pro
Lys Ala Pro Asn
Lys Gly Pro Gln
Lys Gly Gln Pro
Lys Asn Ala Pro
Lys Asn Pro Ala
Lys Pro Ala Asn
Lys Pro Gly Gln
Lys Pro Asn Ala
Lys Pro Gln Gly
Lys Gln Gly Pro
Lys Gln Pro Gly
Leu Ala Glu Pro
Leu Ala Pro Glu
Leu Cys Pro Pro
Leu Glu Ala Pro
Leu Glu Pro Ala
Leu Pro Ala Glu
Leu Pro Cys Pro
Leu Pro Glu Ala
Leu Pro Pro Cys
Asn Ala Lys Pro
Asn Ala Pro Lys
Asn Ala Pro Gln
Asn Ala Gln Pro
Asn Lys Ala Pro
Asn Lys Pro Ala
Asn Pro Ala Lys
Asn Pro Ala Gln
Asn Pro Lys Ala
Asn Pro Gln Ala
Asn Gln Ala Pro
Asn Gln Pro Ala
Pro Ala Glu Ile
Pro Ala Glu Leu
Pro Ala Ile Glu
Pro Ala Lys Asn
Pro Ala Leu Glu
Pro Ala Asn Lys
Pro Ala Asn Gln
Pro Ala Gln Asn
Pro Cys Ile Pro
Pro Cys Leu Pro
Pro Cys Pro Ile
Pro Cys Pro Leu
Pro Asp Val Val
Pro Glu Ala Ile
Pro Glu Ala Leu
Pro Glu Ile Ala
Pro Glu Leu Ala
Pro Gly Lys Gln
Pro Gly Gln Lys
Pro Gly Gln Gln
Pro Ile Ala Glu
Pro Ile Cys Pro
Pro Ile Glu Ala
Pro Ile Pro Cys
Pro Lys Ala Asn
Pro Lys Gly Gln
Pro Lys Asn Ala
Pro Lys Gln Gly
Pro Leu Ala Glu
Pro Leu Cys Pro
Pro Leu Glu Ala
Pro Leu Pro Cys
Pro Asn Ala Lys
Pro Asn Ala Gln
Pro Asn Lys Ala
Pro Asn Gln Ala
Pro Pro Cys Ile
Pro Pro Cys Leu
Pro Pro Ile Cys
Pro Pro Leu Cys
Pro Gln Ala Asn
Pro Gln Gly Lys
Pro Gln Gly Gln
Pro Gln Lys Gly
Pro Gln Asn Ala
Pro Gln Gln Gly
Pro Val Asp Val
Pro Val Val Asp
Gln Ala Asn Pro
Gln Ala Pro Asn
Gln Gly Lys Pro
Gln Gly Pro Lys
Gln Gly Pro Gln
Gln Gly Gln Pro
Gln Lys Gly Pro
Gln Lys Pro Gly
Gln Asn Ala Pro
Gln Asn Pro Ala
Gln Pro Ala Asn
Gln Pro Gly Lys
Gln Pro Gly Gln
Gln Pro Lys Gly
Gln Pro Asn Ala
Gln Pro Gln Gly
Gln Gln Gly Pro
Gln Gln Pro Gly
Ser His Ser Val
Ser His Val Ser
Ser Ser His Val
Ser Ser Val His
Ser Val His Ser
Ser Val Ser His
Thr Ala His Thr
Thr Ala Thr His
Thr His Ala Thr
Thr His Thr Ala
Thr Thr Ala His
Thr Thr His Ala
Val Asp Pro Val
Val Asp Val Pro
Val His Ser Ser
Val Pro Asp Val
Val Pro Val Asp
Val Ser His Ser
Val Ser Ser His
Val Val Asp Pro
Val Val Pro Asp
ZK118182 isopropyl ester
Austalide L
Taraxacolide 1-O-b-D-glucopyranoside
9beta-hydroxy-11beta,13-dihydro-parthenolide-9-O-beta-D-glucopyranoside
9alpha-hydroxy-11beta,13-dihydro-parthenolide-9-O-beta-D-glucopyranoside
1H-Azepine,hexahydro-1-[[[1-[2-(4-methyl-1-piperidinyl)-2-oxoethyl]-1H-benzimidazol-2-yl]thio]acetyl]-(9CI)
Pregna-1,4-dien-21-al, 16,17-[butylidenebis(oxy)]-11-hydroxy-3,20-dioxo-, (11β,16α)
5-O-tert-Butyldiphenylsilyl-2,3-O-isopropylidene-D-ribofuranose
2,2-azobis[2-[1-(2-hydroxyethyl)-2-imidazolin-2-yl]propane] dihydrochloride monohydrate
Bedoradrine
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
1H-Benzimidazole-1-acetamide,N-cyclopentyl-2-[[2-(2,6-dimethyl-1-piperidinyl)-2-oxoethyl]thio]-(9CI)
HEXOCYCLIUM METHYLSULFATE
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
Dopexamine hydrochloride
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Dopexamine hydrochloride is a β2 adrenergic receptor agonist.
9-Cyclopentyl-6-[2-(3-imidazol-1-YL-propoxy)-phenylamino]-9H-purine-2-carbonitrile
N~2~-[(Benzyloxy)carbonyl]-N-[(1S,2S)-2-hydroxy-1-(4-hydroxybenzyl)propyl]-L-leucinamide
N-[2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl]naphthalene-2-carboxamide
CAY10594 is a potent phospholipase D2 (PLD2) inhibitor both in vitro (IC50=140 nM) and in cells (IC50=110 nM)[1]. CAY10594 strongly inhibits the invasive migration of breast cancer cells in vitro and ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis[2].
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate
2-[[4-(2,3-Dimethylphenyl)-1-piperazinyl]-oxomethyl]-1,5-dimethyl-4-pyrrolo[3,2-c]quinolinone
N-(3-fluoro-4-methylphenyl)-4-[3-(4-methyl-1-piperidinyl)propylamino]-3-nitrobenzamide
3-[[cyclopentyl-[[1-(phenylmethyl)-5-tetrazolyl]methyl]amino]methyl]-8-methyl-1H-quinolin-2-one
[(2S,3R)-6-(1,3-benzodioxol-5-ylmethyl)-3-phenyl-1-(phenylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
N-(cyclohexylmethyl)-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-[(1R,3S,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3R,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-(cyclohexylmethyl)-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-[(1R,3R,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3S,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-(cyclohexylmethyl)-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
1-[(3aS,4R,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
N-(cyclohexylmethyl)-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
N-[(1S,3S,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3R,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
1-[(3aR,4S,9bR)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
1-[(3aR,4R,9bR)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
2-[[(2R)-2-(8-carboxyoctanoyloxy)-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-(8-carboxyoctanoyloxy)-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] dodecanoate
Zaldaride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
3,4a,5-trimethyl-6-[(2-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 3-methylbut-2-enoate
(4ar,5r,8ar,9as)-5-hydroxy-3,8a-dimethyl-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-4h,4ah,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-2-one
(2s,3r,4s,5r)-4,5-dihydroxy-2-({2-[(1r,4r)-4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate
2-(3,4-dimethylpent-3-en-1-yl)-3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-2-(methoxymethyl)-3,4-dihydro-1h-quinoline-6-carboximidic acid
(1s,2r,4r,7z,11s,12s)-4,12-dimethyl-8-({[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-13-one
(3s,3as,9r,11as)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
(3s,3ar,4ar,5s,6r,7ar,9ar)-5-hydroxy-3,5,8-trimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,4ah,6h,7h,7ah,9ah-azuleno[6,5-b]furan-2-one
(3s,3as,5ar,6r,9s,9as,9bs)-3,5a,9-trimethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-naphtho[1,2-b]furan-2,8-dione
(3s,3as,9s,11ar)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
19-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
(3s,3ar,4s,6s,7r,7as)-6-ethenyl-4-hydroxy-3,6-dimethyl-7-[(1e)-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl]-hexahydro-1-benzofuran-2-one
3,4a,5-trimethyl-6-[(3-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 3-methylbut-2-enoate
3,5a-dimethyl-2-oxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydronaphtho[1,2-b]furan-9-carbaldehyde
2-{[2-(3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl)propan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate
(1r,3s,4r,6s,7s,8s,9s,10r,13s,14s,16r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
9-(hydroxymethyl)-5a-methyl-3-methylidene-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-2-one
20-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
5,9a-dihydroxy-5b,9,9,11a-tetramethyl-2-(penta-1,3-dien-1-yl)-5,5a,6,7,10,11-hexahydro-1,12-dioxatetraphene-4,8-dione
(3s,3as,9s,11as)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
6-ethenyl-4-hydroxy-3,6-dimethyl-7-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl)-hexahydro-1-benzofuran-2-one
2-(2-hydroxy-1-methoxy-5,6-dimethylhept-5-en-2-yl)-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-2,3-dihydro-1h-indole-5-carboximidic acid
(4s,4ar,5r,6s,8as)-3,4a,5-trimethyl-6-[(3-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl (2z)-2-methylbut-2-enoate
2-{3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}propanoic acid
(2s,3r,4s,5r)-2-({2-[(3r,3ar,5r,7as)-3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate
4,5-dihydroxy-2-({2-[4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate
10-({4-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl}oxy)-10-oxodeca-2,4,6,8-tetraenoic acid
(3s,3ar,4s,6ar,8s,9s,9ar,9br)-4-hydroxy-3,9-dimethyl-6-methylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydroazuleno[4,5-b]furan-2-one
20r,21-epoxyresibufogenin 3-formate
{"Ingredient_id": "HBIN003438","Ingredient_name": "20r,21-epoxyresibufogenin 3-formate","Alias": "NA","Ingredient_formula": "C25H32O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7189","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
20s,21-epoxyresibufogenin 3-formate
{"Ingredient_id": "HBIN003472","Ingredient_name": "20s,21-epoxyresibufogenin 3-formate","Alias": "NA","Ingredient_formula": "C25H32O6","Ingredient_Smile": "CC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C67C=CC(=O)OC6O7)C)OC=O","Ingredient_weight": "428.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7190","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101244896","DrugBank_id": "NA"}